CRP and cancer: Accompany with the advancement of laboratory measurements, some experts have suggested that a lower threshold for CRP (cutoff value: 3 mg/l) may enhance the prognostic value of the mGPS in cancer patients, and a high-sensitivity mGPS (HS-mGPS) has been proposed [4–7].